Evidence mapPaperPMID 31369090Full record

Trial reportThe Journal of clinical endocrinology and metabolism2019

Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial.

Fredrik Rosqvist, Joel Kullberg, Marcus Ståhlman, Jonathan Cedernaes, Kerstin Heurling, Hans-Erik Johansson, David Iggman, Helena Wilking, Anders Larsson, Olof Eriksson and 9 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed, 1 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 1 synthesis or guideline pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Fredrik RosqvistDepartment of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
Joel KullbergDepartment of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
Marcus StåhlmanDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Jonathan CedernaesDivision of Endocrinology, Metabolism and Molecular Medicine, Northwestern University, Chicago, Illinois.
Kerstin HeurlingDepartment of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
Hans-Erik JohanssonDepartment of Public Health and Caring Sciences, Geriatrics, Uppsala University, Uppsala, Sweden.
David IggmanDepartment of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
Helena WilkingDepartment of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
Anders LarssonDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Olof ErikssonAntaros Medical AB, BioVenture Hub, Mölndal, Sweden.
Lars JohanssonDepartment of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
Sara StranieroMetabolism Unit, Endocrinology, Metabolism and Diabetes, and Integrated CardioMetabolic Center, Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Stockholm, Sweden.
Mats RudlingMetabolism Unit, Endocrinology, Metabolism and Diabetes, and Integrated CardioMetabolic Center, Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Stockholm, Sweden.
Gunnar AntoniDepartment of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Mark LubberinkDepartment of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
Marju Orho-MelanderDepartment of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Malmö, Sweden.
Jan BorénDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Håkan AhlströmDepartment of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
Ulf RisérusDepartment of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
Uppsala University · SEKarolinska University Hospital · SEUniversity of Gothenburg · SELund University · SENorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextSaturated fatty acid (SFA) vs polyunsaturated fatty acid (PUFA) may promote nonalcoholic fatty liver disease by yet unclear mechanisms.

objectiveTo investigate if overeating SFA- and PUFA-enriched diets lead to differential liver fat accumulation in overweight and obese humans.

designDouble-blind randomized trial (LIPOGAIN-2). Overfeeding SFA vs PUFA for 8 weeks, followed by 4 weeks of caloric restriction.

settingGeneral community.

participantsMen and women who are overweight or have obesity (n = 61).

interventionMuffins, high in either palm (SFA) or sunflower oil (PUFA), were added to the habitual diet.

main outcome measuresLean tissue mass (not reported here). Secondary and exploratory outcomes included liver and ectopic fat depots.

resultsBy design, body weight gain was similar in SFA (2.31 ± 1.38 kg) and PUFA (2.01 ± 1.90 kg) groups, P = 0.50. SFA markedly induced liver fat content (50% relative increase) along with liver enzymes and atherogenic serum lipids. In contrast, despite similar weight gain, PUFA did not increase liver fat or liver enzymes or cause any adverse effects on blood lipids. SFA had no differential effect on the accumulation of visceral fat, pancreas fat, or total body fat compared with PUFA. SFA consistently increased, whereas PUFA reduced circulating ceramides, changes that were moderately associated with liver fat changes and proposed markers of hepatic lipogenesis. The adverse metabolic effects of SFA were reversed by calorie restriction.

conclusionsSFA markedly induces liver fat and serum ceramides, whereas dietary PUFA prevents liver fat accumulation and reduces ceramides and hyperlipidemia during excess energy intake and weight gain in overweight individuals.

Indexed as

AdultCeramidesDietary FatsDouble-Blind MethodFatty Acids, UnsaturatedFatty LiverFemaleFollow-Up StudiesHumansHyperphagiaLipidsMaleObesityOverweightPrognosisWeight GainCeramidesDietary FatsFatty Acids, UnsaturatedLipids

Identifiers

PMID31369090
PMCPMC6839433
OpenAlexW2964856589

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.